Thoracic Cancer

Aims & Scope

Thoracic Cancer aims to facilitate international collaboration and exchange of comprehensive and cutting-edge information on basic, translational, and applied clinical research in lung cancer, esophageal cancer, mediastinal cancer, breast cancer and other thoracic malignancies.

Prevention, treatment and research relevant to Asia-Pacific is a focus area, but submissions from all regions are welcomed.

The editors encourage contributions relevant to prevention, general thoracic surgery, medical oncology, radiology, radiation medicine, pathology, basic cancer research, as well as epidemiological and translational studies in thoracic cancer.

Thoracic Cancer is the official publication of the Chinese Society of Lung Cancer, International Chinese Society of Thoracic Surgery and is endorsed by the Korean Association for the Study of Lung Cancer and the Hong Kong Cancer Therapy Society.

The Journal publishes a range of article types including: Editorials, Invited Reviews, Mini Reviews, Original Articles, Clinical Guidelines, Technological Notes, Imaging in thoracic cancer, Meeting Reports, Case Reports, Letters to the Editor, Commentaries, and Brief Reports.

Metrics & Ranking

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Directory of Open Access Journals (DOAJ)
• Web of Science
• Embase

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.

Licensing & Copyright

This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.

Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.

Policy Links

This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.

• Aims scope
• Homepage
• Oa statement
• Author instructions
• License terms
• Review url
• Board url
• Copyright url
• Plagiarism url
• Preservation url
• Apc url
• License

Plagiarism Policy

This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.

For more details, please refer to our official: Plagiarism Policy.

APC Details

The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.

This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,750.00 USD. Learn more.

Explore journals without APCs for alternative publishing options.

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Targeting the PI3K/Akt/mTOR pathway in non‐small cell lung cancer (NSCLC)

  Citation: 389

  Authors: Aaron C.

• Epidemiology of lung cancer in China

  Citation: 341

  Authors: Maomao, Wanqing

• Review of aerobic glycolysis and its key enzymes – new targets for lung cancer therapy

  Citation: 250

  Authors: Xue‐bing, Jun‐dong, Qing‐hua

• Epidemiology of esophageal cancer in 2020 and projections to 2030 and 2040

  Citation: 233

  Authors: Chun‐Quan, Yun‐Lei, Qi, Pei‐Hao, Yi, Peng‐Fei, Yong

• <i>ALK‐</i>rearrangement in non‐small‐cell lung cancer (NSCLC)

  Citation: 217

  Authors: Xue, Yun, Hai‐Feng, Yan‐Hong, Hong‐Jun

• Curcumin induces ferroptosis in non‐small‐cell lung cancer via activating autophagy

  Citation: 206

  Authors: Xin, Hui, Maoli, Xing, Yuxia, Nansheng, Qianqian, Jing, Jie

• Esophageal cancer statistics in <scp>C</scp>hina, 2011: Estimates based on 177 cancer registries

  Citation: 191

  Authors: Hongmei, Rongshou, Siwei, Tingting, Changfa, Xiaonong, Wanqing

• Traditional <scp>C</scp>hinese medicine and cancer: History, present situation, and development

  Citation: 165

  Authors: Jie, Shuo, Ying, Hui‐ting, Hong‐sheng

• Quercetin induces pro‐apoptotic autophagy via <scp>SIRT1</scp>/<scp>AMPK</scp> signaling pathway in human lung cancer cell lines <scp>A549</scp> and <scp>H1299</scp> in vitro

  Citation: 154

  Authors: Hengjuan, Hui, Xin, Maoli, Shuo, Jing, Jie

• Epidemiology of lung cancer in <scp>C</scp>hina

  Citation: 128

  Authors: Wanqing, Rongshou, Hongmei, Siwei